in the news/ businessweekly.co.uk
Sphere Fluidics in €3.4m cancer campaign
Cambridge life science company Sphere Fluidics is part of a consortium awarded €3.4 million for an important new cancer research programme.
3DSecret is a four-year research project funded through the European Innovation Council’s Pathfinder Open 2022, established under Horizon Europe.
Coordinated by the International Iberian Nanotechnology Laboratory, its mission is to develop novel technologies to investigate the stochastic patterns behind metastasis at the single-cell level to predict cancer evolution.
3DSecret brings together multidisciplinary experts in microfluidics, nanosensors, artificial intelligence, cell genomics and transcriptomics from four European countries – Portugal, Spain, Italy and the UK.
Sphere Fluidics is providing its patented picodroplet technology to support the development of an integrated microfluidic device, the 3DSecret-chip, for the reproducible and controlled formation of 3D spheroids from single cancer cells…